OBJECTIVE: Placental 11b-hydroxysteroid dehydrogenase type 2 (11b-HSD2) operates as a functional barrier to protect the fetus from excessive exposure to maternal cortisol. Previous studies using animal models have demonstrated that prenatal stress can influence the expression of glucocorticoids related genes, reducing placenta function of 11B-HSD-2 which ultimately lead to suboptimal fetal growth. However, the influence of maternal stress on fetal outcomes, as well as the influence on the expression of the enzyme in the human placenta has not been previously described. The objective of this study was to determine the role of maternal stress in suboptimal fetal growth and its relation with RNA expression and DNA methylation of the placental 11b-HSD2. STUDY DESIGN: Nested case-control study in full-term singleton gestations. The Perceived Stress Scale (PSS) and the state-trait anxiety inventory were assessed in mothers of pregnancies with antenatal suspicion of sub-optimal fetal growth that subsequently delivered a small for gestational age (SGA) neonate [birthweight<10 th centile; n¼205] and in a control group who delivered normally grown neonates (n¼247). In addition, in a subset of patients (n¼35 cases and 26 controls), RNA expression levels of placental 11b-HSD2 were analyzed, as well as the extent of DNA methylation (four CpG sites) of the locus. (Figure 1) . No differences were found in the average or mean percentage of placental 11b-HSD2 methylation between cases and controls. However, when groups were subdivided according to the presence of maternal stress, SGA cases with maternal stress (n¼12) had a significantly different median level of methylation compared to controls [8.3 % (7.6 -10.3) vs. 11.4 % (10.2 -13.1); p¼0.02] (Figure 2) . CONCLUSION: Our findings suggest a significant association between pregnant women's stress and suboptimal fetal growth, affecting RNA expression and DNA methylation of glucocorticoids-related placental genes.
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